Skip to main content
Clinical Case Reports logoLink to Clinical Case Reports
. 2017 Dec 21;6(2):262–266. doi: 10.1002/ccr3.1105

Parotid swelling after Russell's viper envenomation: an unusual and poor prognostic sign

Maanoj N Sasidaran 1,2, Stephen P Samuel 1,3, Soundararaj ChinnaRaju 1, Michael Antonysamy 2, Tommaso C Bulfone 4, Matthew R Lewin 5,
PMCID: PMC5799621  PMID: 29445459

Key Clinical Message

Parotid swelling, an unusual and poorly understood sign, is associated with poor prognosis in the setting of Russell's viper envenomation. The large, aggressive Russell's viper is one of the most deadly snakes causing severe hematological and neurological manifestations. Research into this sign should be initiated and understanding could lead to improved outcomes.

Keywords: Antivenom, coagulopathy, dialysis, Russell's viper

Introduction

Snakebite remains one of the most neglected tropical maladies in the developing world. An estimated five million snakebites occur worldwide of which two million are venomous with 125,000 deaths and 400,000 limb deformities 1, 2, 3. Approximately 10,000 people may die during each month of monsoon due to snakebite in India 4. Government reporting of snakebite deaths depends on hospital reports, but it is estimated that more than 75% of mortality occurs outside the hospital 5. Thus, the numbers of deaths reported by government agencies are thought to underestimate the true toll of death and disability by snakebite 5. The common venomous snake species in India are Spectacled cobra (Naja naja), Saw‐scaled viper (Echis carinatus), Russell's viper (Daboia russelii), and Common Krait (Bungarus caeruleus) 6, and are the target of commercially available polyvalent antivenoms of varying quality. Unfortunately, only 70–85% of bites are by these species and with the large number of bites, many patients cannot receive either specific or appropriately effective polyvalent antivenom therapy even if they reach a hospital. Snakebite remains an important public health hazard in India, affecting more than 800 million people living in rural settings and multiple potential exposures in and around domiciles and in the fields. Depending on factors such as bite depth, venom dose, and host factors such as size, age, and comorbidity, signs and symptoms of Russell's viper envenomation appear almost immediately, in a few minutes or few hours after a bite. A typical venomous bite includes severe, immediate pain with rapid swelling, bruising of the skin, and difficulty in breathing. Many victims have a metallic, rubbery or minty taste in the mouth, numbness or tingling around the mouth, tongue, scalp, feet, or the bite area, swelling in lymph nodes near the bite, and signs of shock. A significant percentage will develop hypopituitarism, acute renal failure, myocardial infarction, ventricular tachycardia, and neurological manifestations that may supervene, especially from Russell viper bite in the southern regions of India and Sri Lanka 7, 8, 9, 10, 11, 12. Because of the large number of bites, even these lower percentage complications can be seen as “common” when considered in such large populations being affected. A more unusual complication is development of parotid gland swelling. It is our experience and that of others that this finding is associated with poor prognosis 13, 14, 15, 16, 17. The mechanism by which parotid gland swelling occurs is not documented and does not fit easily into the usual categories of suppurate (e.g., Staphylococcus infection) or viral (e.g., mumps) or noninfectious causes such as gout or uremia 18. To our knowledge, no literature describes imaging or histopathological findings associated with this finding although such knowledge might lead to clues about how to treat these patients and others.

Case Report

A 37‐year‐old farmer spraying his field was bitten on his left foot by a Russell's viper (Daboia russelii) just before noon on the 31st of December 2015. He was taken to a local hospital where four vials of antivenom were administered before referral to our tertiary facility. He was admitted to our hospital approximately 4 h after the snakebite. In our Emergency Department, he presented with severe pain and bleeding at the bite site, throat irritation, difficulty breathing, and ptosis likely both as an acute reaction to venom and antivenom. He was treated upon arrival to emergency department for allergic reaction and with 30 additional vials of VINS antivenom, tetanus toxoid, and antibiotics. Within 12 h, he developed enlargement of the parotid glands without other signs of peripheral edema or capillary leak (Fig. 1) followed by hematuria and oliguria 17. His other salivary glands appeared and palpated normal. His coagulation profile improved on the second day (Table 1), but within 36 hours he developed acute kidney injury (Table 2). His kidneys were then supported by 13 cycles of hemodialysis. His respiration was assisted by mechanical ventilation from day 1 until his death (Day 16). The patient became unarousable on the 11th day of admission. An urgent CT scan showed no intracranial bleeding but diffuse brain edema and pansinusitis. The patient was treated with broad‐spectrum antibiotics and a trial of intravenous neostigmine while his hydration and nutritional needs were monitored throughout. Throughout the course of patient's stay in the hospital, his next of kin were regularly updated about the clinical progress and severity of the envenomation. Figure 2 illustrates the timeline of events and clinical course.

Figure 1.

Figure 1

Parotid swelling appeared approximately 12 h after the bite (red arrow).

Table 1.

Coagulation results

Test Day 1 Day 2
Bleeding time Beyond normal range 6 min 35 sec
Clotting time Not clotting 12 min 25 sec

Table 2.

Biochemistry

Parameters Day 1 Day 3 Day 5 Day 7 Day 9 Day 11 Day 13 Day 15
WBC (4–10 × 103/μL) 16.0 16.6 2.4 14.3 17.7 19.7 10.6 12.2
HGB (12–16 g/dL) 17.8 15.8 10.7 11.6 11.3 17.0a 11.8 12.3
PLT (100–300 × 103/μL) 201 140 33 34 31 47 80 94
Blood sugar (80–160 mg %) 159 219 142 116 167 121 197 174
Blood Urea Nitrogen (15–40 mg %) 40 76 98 110 229 218 224 169
Creatinine (0.6–1.2 mg %) 1.1 2.1 4.7 4.8 4.6 4.5 4.7 2.4
Potassium (3.48–5.50 mmol/L) 2.93 3.65 2.59 3.67 4.06 2.95 4.41 3.82
a

Uncertain accuracy. Patient was not transfused.

Figure 2.

Figure 2

Timeline of events and clinical course. ASV = antivenom.

Investigations

Serial laboratory investigations were carried out to help guide clinical management. Initially, the whole‐blood clotting time (Table 1) was more than 20 min despite the initial four vials of antivenom and improved significantly by day 2. The microscopic examination of the patient's urine showed a multitude of RBCs. There was a progressive deterioration of renal function and thrombocytopenia (Table 2). CT of the brain was performed because of coagulopathy and unexplained drowsiness. Imaging showed diffuse brain edema and pansinusitis but no signs of intracranial hemorrhage. Images of the parotids were not obtained.

Discussion

Most of snakebites occur in impoverished areas of India, sub‐Saharan Africa, and Southeast Asia. Russell's viper is one of the most dangerous snakes found in Asia. A southern state of Tamil Nadu, India, is estimated to have at least 10,000 deaths each year and is just one of many states in India greatly affected by snakebite 3. Viper envenomation presentation varies from minor localized signs to life threatening systemic manifestations in up to 92% of cases, as Russell's viper is both a large and highly aggressive snake 19. Apart from unusual complications such as ventricular tachycardia, myocardial infarction, and hypopituitarism 7, there is evidence that bilateral parotid swelling may occur and is associated with poor prognosis 14, 15, 16. However, only a few cases of isolated parotid swelling following snakebite have been reported. 14, 15, 16, 17. Indian National snakebite protocol 2007 also states that parotid swelling is associated with poor prognosis 15.

Our patient travelled 25 km from his village to a local hospital where he was treated with four vials of antivenom and was then shifted to our hospital, which is another 45 km. He was treated with a total of 34 vials of antivenom, early fasciotomy (a controversial practice, but standard of care in this hospital) 18, 19, 20, 21, antibiotics, mechanical ventilation, neostigmine, and dialysis. In spite of aggressive management, our patient died of multi‐organ failure. Autopsy was not carried out and is unusual for a private hospital serving the poor and a known cause of death (snakebite). The cause of parotid swelling in viper bite is unknown, but it seems to represent a poor prognostic outcome 17, 20. Nevertheless, it is imperative that both acute care physicians and nursing staff are well informed in detecting parotid swelling in a much earlier stage in view of its prognostic significance. More research is needed to delineate the exact pathogenesis to establish this as a prognostic sign in viper envenomation. Reporting such case reports will sharpen the awareness of medical and nursing staff to redouble treatment and resuscitation efforts immediately upon receiving a suspected Russell's viper envenomation. The pathophysiology behind snakebite‐induced parotid swelling has not been established but recently is subject of growing interest. 17, 18. It would be desirable to image and possibly biopsy such a finding as it could eventually lead to better understanding of pathophysiology and ultimately, better treatments. In this case, failure to image parotids by ultrasound or CT was a lost opportunity and should be considered in future cases.

Authorship

MNS: contributed to the manuscript. SPS: contributed to patient care and wrote the manuscript. SCR: contributed to patient care and wrote the manuscript. MA: involved in background research and wrote the manuscript. TCB: contributed to the manuscript and background research. MRL: involved in background research and wrote the manuscript.

Conflict of Interest

None declared.

Clinical Case Reports 2018; 6(2): 262–266

All authors contributed equally.

References

  • 1. Chippaux, J. P. 1998. Snake‐bites: appraisal of the global situation. Bull. World Health Organ. 76:515–524. [PMC free article] [PubMed] [Google Scholar]
  • 2. Kasturiratne, A. , Wickremasinghe A. R., de Silva N., Gunawardena N. K., Pathmeswaran A., Premaratna R. et al. 2008. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 5:e218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Vaiyapuri, S. , Vaiyapuri R., Ashokan R., Ramasamy K., Nattamaisundar K., Jeyaraj A. et al. 2013. Snakebite and its socio‐economic impact on the rural population of Tamil Nadu, India. PLoS ONE 8:e80090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Meenatchisundaram, S. , and Michael A.. 2009. Snake bite and therapeutic measures: Indian scenario. Indian J. Sci. Technol. 2:69–73. [Google Scholar]
  • 5. Mohapatra, B. , Warrell D. A., Suraweera W., Bhatia P., Dhingra N., Jotkar R. M. et al. 2011. Snakebite mortality in India: a nationally representative mortality survey. PLoS Negl. Trop Dis. 5:e1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Kumar, V. , Maheshwari R., and Verma H. K.. 2006. Toxicity and symptomatic identification of species involved in snakebites in the Indian subcontinent. J. Venom. Anim. Toxins Incl. Trop. Dis. 12:3–18. [Google Scholar]
  • 7. Antonypillai, C. N. , J. A. H. Wass, Warrell D. A., and Rajaratnam H. N.. 2011. Hypopituitarism following envenoming by Russell's vipers (Daboia siamensis and D. russelii) resembling Sheehan's syndrome: first case report from Sri Lanka, a review of the literature and recommendations for endocrine management. QJM 104:97–108. [DOI] [PubMed] [Google Scholar]
  • 8. Dissanayake, P. , and Sellahewa K. H.. 1996. Acute myocardial infarction in a patient with Russell's viper bite. Ceylon Med. J. 41:67–68. [PubMed] [Google Scholar]
  • 9. George, A. , Tharakan V. T., and Solez K.. 1987. Viper bite poisoning in India: a review with special reference to renal complications. Ren. Fail. 10:91–99. [DOI] [PubMed] [Google Scholar]
  • 10. Silva, A. , Pilapitiya S., and Siribaddana S.. 2012. Acute myocardial infarction following a possible direct intravenous bite of Russell's viper (Daboia russelli). BMC Res. Notes 5:500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Thewjitcharoen, Y. , and Poopitaya S.. 2005. Ventricular tachycardia, a rare manifestation of Russell's viper bite: case report. J. Med. Assoc. Thai. 88:1931–1933. [PubMed] [Google Scholar]
  • 12. Warrell, D. A. 1989. Snake venoms in science and clinical medicine. 1. Russell's viper: biology, venom and treatment of bites. Trans. R. Soc. Trop. Med. Hyg. 83:732–740. [DOI] [PubMed] [Google Scholar]
  • 13. National Snake Bite Management Protocol . 2009. General signs and symptoms of viperine envenomation. p. 14 Available at http://www.statehealthsocietybihar.org/nationalsnakebitemanagementprotocol.pdf (accessed 02 February 2017).
  • 14. Chakraborty, P. P. , and Bhattacharjee R.. 2010. Bilateral parotid swelling: an unusual complication of viper bite. J. Assoc. Physicians India 58:460. [PubMed] [Google Scholar]
  • 15. Deepak, M. , Basavaprabhu A., Ramapuram J.T., Nithyananda C., and Mahalingam S.. 2013. Bilateral parotid enlargement following snake bite: a rare sign. Asian Pac. J. Trop. Biomed. 3:154–155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Sarkar, S. , and Sarkar J. K.. 2015. Bilateral parotid swelling after viper envenomation: an ominous sign? Indian Pediatr. 52:161–162. [PubMed] [Google Scholar]
  • 17. Udayabhaskaran, V. , Arun Thomas E. T., and Shaji B.. 2017. Capillary leak syndrome following snakebite Envenomation. Indian J Crit Care Med 21:698–702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Al‐Dajani, N. , and Wootton S. H.. 2007. Cervical lymphadenitis, suppurative parotitis, thyroiditis, and infected cysts. Infect. Dis. Clin. North Am. 21:523–541, viii. [DOI] [PubMed] [Google Scholar]
  • 19. Alirol, E. , Sharma S. K., Bawaskar H. S., Kuch U., and Chappuis F.. 2010. Snake bite in South Asia: a review. PLoS Negl. Trop Dis. 4:e603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Paul, V. , Pratibha S., Prahlad K. A., Earali J., Francis S., and Lewis F.. 2004. High‐dose anti‐snake venom versus low‐dose anti‐snake venom in the treatment of poisonous snake bites–a critical study. J. Assoc. Physicians India 52:14–17. [PubMed] [Google Scholar]
  • 21. Singh, S. , and Singh G.. 2013. Snake bite: Indian Guidelines and Protocol. Medicine update of API 94:424–426. [Google Scholar]

Articles from Clinical Case Reports are provided here courtesy of Wiley

RESOURCES